癌细胞内在的机制驱动获得的免疫耐受性
Ehsan Ghorani1, Charles Swanton2, Sergio A Quezada3
1Cancer Immunology and Immunotherapy Unit, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Medical Oncology, Imperial College London Hospitals, London, UK.
Immunity
|October 11, 2023
概括
癌细胞通过控制维持自我容忍的途径来逃避免疫破坏. 了解这些癌细胞内在因素是开发针对免疫逃避和改善患者分层的新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 免疫逃避是一种关键的机制,使瘤能够抵抗宿主免疫反应.
- 癌细胞开发了内在的策略,以避免免疫识别和T细胞的破坏.
研究的目的:
- 审查癌细胞内在的驱动免疫逃避的因素.
- 基于对T细胞功能的控制来对免疫逃避机制进行分类.
主要方法:
- 文献综述侧重于癌细胞内在的免疫逃避机制.
- 框架开发,对与T细胞局部化,抗原识别和效应器功能相关的逃避策略进行分类.
主要成果:
- 癌细胞劫持自我耐受路径,以逃避免疫破坏.
- 逃避的机制包括控制T细胞局部化,抗原识别和效应器功能.
- 在癌症免疫逃避中存在显著的途径冗余.
结论:
- 针对癌细胞内在的免疫逃避,需要对这些多方面的机制有全面的了解.
- 需要开发更好的工具,以便在基于免疫逃避概况的临床试验中对患者进行分层.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Cell-mediated Immune Responses
68.6K
Overview
68.6K
Special Features of Adaptive Immunity
841
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
841
Cytotoxic T Cells-mediated Immune Response
951
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
951
T Cell Activation and Clonal Selection
774
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
774


